TrialJAMA oncology2019
Efficacy and Safety of Pembrolizumab for Heavily Pretreated Patients With Advanced, Metastatic Adenocarcinoma or Squamous Cell Carcinoma of the Esophagus: The Phase 2 KEYNOTE-180 Study.
Manish A Shah et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
312 papers cite itlatest 60 shown
this paperpooled ittrialcites it